PNC Financial Services Group’s ACELYRIN SLRN Stock Holding History

PNC Financial Services Group’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-71	Closed	-$175	–	5063
2025 Q1	$175	Buy	71 +18	+34%	+$43	﹤0.01%	4789
2024 Q4	$166	Hold	53	–	–	﹤0.01%	4665
2024 Q3	$261	Hold	53	–	–	﹤0.01%	4650
2024 Q2	$234	Buy	+53	New	+$248	﹤0.01%	4642
2024 Q1	–	Sell	-2	Closed	-$15	–	4806
2023 Q4	$15	Buy	+2	New	+$17	﹤0.01%	4602
2023 Q3	–	Sell	-215	Closed	-$4.49K	–	4740
2023 Q2	$4.49K	Buy	+215	New	+$4.4K	﹤0.01%	4140

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PNC Financial Services Group's SLRN Position: Q2 2025 in Review

PNC Financial Services Group sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 71 shares — an estimated $175 sold.

PNC Financial Services Group first reported a position in SLRN in Q2 2023 and held it in 6 quarters. The position peaked at $4.49K in Q2 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

PNC Financial Services Group reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
PNC Financial Services Group sold 71 ACELYRIN shares in Q2 2025, an estimated $175.
PNC Financial Services Group first reported a position in ACELYRIN in Q2 2023 and held it in 6 quarters.
PNC Financial Services Group's ACELYRIN position peaked at $4.49K in Q2 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.